Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Filed Chapter 11
Appointed CFO
Quarterly results
Acq. announced
Director departure
CHEM RX CORP (CHRX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/22/2011
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
06/17/2010
8-K
Quarterly results
05/12/2010
8-K
Filed for Chapter 11
Docs:
"
CHEM RX FILES CHAPTER 11 TO FACILITATE REORGANIZATION
"
01/22/2010
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
01/19/2010
8-K
Form 8-K - Current report
06/16/2009
8-K
Form 8-K - Current report
05/04/2009
8-K
Other Events, Financial Statements and Exhibits
Docs:
"
CHEM RX CORPORATION ENTERS SHORT-TERM FORBEARANCE AGREEMENTS WITH LENDERS LONG BEACH, N.Y., May 1, 2009 – Chem Rx Corporation , a leading provider of institutional pharmacy services, today announced that it has signed 45-day forbearance agreements with the requisite lenders under its two primary credit facilities. Per the agreements, lenders under the two credit facilities forebear from exercising certain rights and remedies until June 15, 2009. The Company intends to use the forbearance period to continue to negotiate appropriate waivers or amendments to its credit facilities with the lenders. As previously announced, the Company was in technical violation of three financial covenants under its credit facilities and has not paid its default interest. The covenants require the Company to m...
"
04/17/2009
SC 13D/A
Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
04/01/2009
8-K
Form 8-K -- Current report
04/01/2009
NT 10-K
Form NT 10-K -- Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
02/13/2009
SC 13G/A
MHR FUND MANAGEMENT LLC has filed a Schedule 13D for Chem Rx Corporation
02/12/2009
SC 13G/A
Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/09/2009
SC 13G/A
Pine River Capital Management L.P. reports a 4.1% stake in Chem RX Corporation
01/28/2009
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
01/21/2009
4
LOBELL J JAY (Director) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
SELZER EVAN (Executive Vice President) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
SIEGEL LESLIE (VP - OPS & TECHNOLOGY) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
AGOGLIA PAULA (VP - OPS & CLIENT SERVICING) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
KELLMAN DAVID J (Director) has filed a Form 4 on CHEM RX CORP
01/20/2009
4
JACOBS GARY MARK (CFO) has filed a Form 4 on CHEM RX CORP
01/20/2009
8-K
Form 8-K -- Current report
01/14/2009
4
SILVA STEVEN C (President and COO) has filed a Form 4 on CHEM RX CORP
01/14/2009
4
SILVA JERRY (Chairman and CEO) has filed a Form 4 on CHEM RX CORP
12/29/2008
8-K
Form 8-K -- Current report
11/25/2008
DEF 14A
Form DEF 14A - Other definitive proxy statements:
11/14/2008
10-Q
Quarterly Report for the period ended September 30, 2008
11/14/2008
8-K
Quarterly results
Docs:
"
Gary M. Jacobs Chief Financial Officer Chem Rx Corporation 516-889-8770 Stephanie Carrington The Ruth Group 646-536-7017
[email protected]
Chem Rx Corporation Reports Third Quarter 2008 Financial Results - Conference Call Scheduled for Friday, November 14, 2008 at 8:30 a.m. ET - Recent Highlights:
"
11/04/2008
8-K
Form 8-K -- Current report
09/24/2008
8-K
Form 8-K -- Current report
08/14/2008
10-Q
Quarterly Report for the period ended June 30, 2008
08/14/2008
8-K
Quarterly results
Docs:
"
Exhibit 99.1 Gary M. Jacobs Chief Financial Officer Chem Rx Corporation 516-889-8770 Stephanie Carrington / Jared Hoffman The Ruth Group 646-536-7017 / 7013
[email protected]
[email protected]
Chem Rx Corporation Reports Second Quarter 2008 Financial Results - Conference Call Scheduled Thursday, August 14, 2008 at 8:30 a.m. ET - Recent Highlights:
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy